Skip to Main content Skip to Navigation
Journal articles

Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.

Abstract : PURPOSE: The aim of this study is to define and illustrate metrics for the external evaluation of a population model. MATERIALS AND METHODS: In this paper, several types of metrics are defined: based on observations (standardized prediction error with or without simulation and normalized prediction distribution error); based on hyperparameters (with or without simulation); based on the likelihood of the model. All the metrics described above are applied to evaluate a model built from two phase II studies of gliclazide. A real phase I dataset and two datasets simulated with the real dataset design are used as external validation datasets to show and compare how metrics are able to detect and explain potential adequacies or inadequacies of the model. RESULTS: Normalized prediction errors calculated without any approximation, and metrics based on hyperparameters or on objective function have good theoretical properties to be used for external model evaluation and showed satisfactory behaviour in the simulation study. CONCLUSIONS: For external model evaluation, prediction distribution errors are recommended when the aim is to use the model to simulate data. Metrics through hyperparameters should be preferred when the aim is to compare two populations and metrics based on the objective function are useful during the model building process.
Complete list of metadatas

Cited literature [21 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00189557
Contributor : Emmanuelle Comets <>
Submitted on : Wednesday, November 21, 2007 - 12:41:05 PM
Last modification on : Friday, October 23, 2020 - 4:37:20 PM
Long-term archiving on: : Monday, April 12, 2010 - 3:03:52 AM

Identifiers

Collections

Citation

Karl Brendel, Emmanuelle Comets, Céline Laffont, Christian Laveille, France Mentré. Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.. Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2006, 23 (9), pp.2036-49. ⟨10.1007/s11095-006-9067-5⟩. ⟨inserm-00189557⟩

Share

Metrics

Record views

690

Files downloads

1257